跳至主要内容
临床试验/TCTR20201222006
TCTR20201222006招募中1 期

Safety evaluation and effect of consumption of Mulberry Capsule on the alterations of clinical symptoms and ischemic stroke biomarkers in transient ischemic attack and ischemic stroke patients

Health Systems Research Institute, Thailand (HSRI)0 个研究点目标入组 60 人开始时间: 2020年12月22日最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 70 Years(—)
性别
All

入选标准

  • 1. Acute ischaemic stroke within the past 5-10 days that caused hemiparesis or hemiplegia
  • 2. Aged between 18 years and 70 years
  • 3. Fugl-Meyer motor scale (FMMS) scores of 55 or less at baseline

排除标准

  • 1. Post rt-PA
  • 2. Severe post-stroke disability (NIHSS score >20)
  • 3. Previous stroke with motor deficit, comprehension deficits (aphasia)
  • 4. Previous depression or MADRS score of more than 19; taking antidepressant drugs, monoamine oxidase inhibitors, neuroleptic drugs, or benzodiazepines during the month before inclusion
  • 5. Undergoing carotid endarterectomy
  • 6. Pregnancy
  • 7. Major diseases that would prevent follow-up. Enrolment, follow-up

研究者

发起方
Health Systems Research Institute, Thailand (HSRI)

相似试验